Skin prick test solution for dust mite allergy
Part of Immune system & allergy clinical trials.
This trial is testing a new skin prick test solution to see if it works well for diagnosing Blomia tropicalis dust mite allergy. It might help improve allergy testing for people with this common allergy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 64 years old.
- You must have a history of allergy symptoms (like sneezing, runny nose, itchy eyes, or asthma) caused by Blomia tropicalis dust mites.
- A skin prick test for Blomia tropicalis must show a wheal (a raised bump) of at least 3 mm in diameter, or you must have a positive blood test for specific IgE.
- You must not have had allergy immunotherapy (allergy shots) for Blomia or related allergens in the last 5 years.
- If you are a woman who can become pregnant, you must have a negative pregnancy test, use effective contraception during the trial, and not be breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.
This study tests a daily under-the-tongue tablet or drops to reduce allergy symptoms caused by house dust mites. If you have allergic rhinitis and are bothered by dust mites, this treatment might help your nose feel better without needing shots.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
Hear when a new Allergic Reactions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.